Renvela 800 mg (Sevelamer Carbonate TABLET) 800 MG

RENVELA 800 MG tablets contain sevelamer carbonate, a phosphate binder used to manage high phosphate levels in the blood. This medication is commonly prescribed for patients undergoing dialysis.

Strength

800 MG

Pack Size

30/180

Manufacturer / TM Owner

SANOFI-AVENTIS CANADA INC

Select Quantity

Pack/s

Request a Quote

Please fill out the form below and our team will get back to you shortly with pricing and further information.

First Name

Last Name

Phone

Delivery Country

Delivery PostCode/Zipcode

Select Your Profile

I have read and agree to the terms & conditions, including the privacy policy, return policy, and usage terms as applicable to this request.

Indications & Clinical Uses

RENVELA 800 MG tablets are primarily used to control phosphate levels in individuals with chronic kidney disease who are on dialysis. By binding to dietary phosphate in the gastrointestinal tract, sevelamer carbonate helps to reduce the absorption of phosphate, which can accumulate to harmful levels in the blood. This medication is often part of a broader treatment plan to manage kidney-related health issues.

Side Effects

Common effects of RENVELA 800 MG tablets may include gastrointestinal discomfort, such as nausea, vomiting, or diarrhea. Some users might also experience constipation or abdominal pain. These effects are generally mild and temporary, but persistent or severe symptoms should be discussed with a healthcare provider.

Precautions & Warnings

RENVELA 800 MG tablets should be taken as directed by a healthcare professional. It is important to follow the prescribed dosage and administration instructions. Patients should inform their healthcare provider about any other medications they are taking to avoid potential interactions. Additionally, individuals with a history of bowel obstruction or severe digestive issues should use this medication with caution.

Avoid Interactions

RENVELA 800 MG tablets may interact with certain medications, including those that require careful monitoring of blood levels. It is advisable to consult a healthcare provider before taking this medication with other drugs, especially those metabolized by the liver or kidneys. Alcohol and other substances that affect digestion may also influence the effectiveness of sevelamer carbonate.

Frequently Asked Questions

RENVELA 800 MG tablets are used to manage high phosphate levels in the blood, commonly in patients with chronic kidney disease who are on dialysis.

RENVELA 800 MG tablets should be taken orally, typically with meals, as directed by a healthcare provider.

Common side effects may include gastrointestinal discomfort, nausea, vomiting, diarrhea, constipation, and abdominal pain.

Potential interactions with other medications should be discussed with a healthcare provider to ensure safety and effectiveness.

RENVELA 800 MG may not be suitable for individuals with certain medical conditions, such as bowel obstruction or severe digestive issues.

Published by

GNH India Pharmaceuticals Limited

Licensed pharmaceutical supplier

Last updated: 29 Jul 2026

Disclaimer

At GNH India, we aim to provide information that is expert-reviewed, accurate, and reliable. However, all content on this platform is intended for general informational purposes only and does not constitute professional medical advice, diagnosis, or treatment. While efforts are made to maintain accuracy and currency, the information may contain errors, omissions, or may not reflect the latest developments. Always consult a qualified healthcare professional regarding any medical concerns.

All product names, brand names, trademarks and registered trademarks displayed on this website are the property of their respective owners. This website and its operator are not affiliated with, endorsed by, or authorized by any such trade mark owners unless expressly stated. Any reference to product names or trademarks is made solely for descriptive and informational purposes. No commercial relationship, sponsorship, approval, or association with any trademark owner should be inferred. Information provided herein does not constitute promotion, advertising, or an offer for sale of any medicinal product and is intended solely for general informational purposes.

All trademarks and brand names displayed on this website are used strictly in accordance with the provisions of the Trade Marks Act, 1999, specifically Sections 30 and 30(1) governing fair use. Trademark ownership has been accurately attributed under the "Manufacturer/ TM Owner" section in compliance with statutory requirements.